Overview
- Emami said in a regulatory filing that it has signed a definitive pact to buy the remaining 73.5% of Axiom Ayurveda for a price capped at Rs 200 crore.
- The company expects to close the purchase in phases over about three months subject to customary conditions, after which Axiom will become a subsidiary.
- Management described the move as a formal entry into the fast-growing beverage category anchored in health-focused products such as aloe vera fruit drinks.
- Axiom’s flagship Alofrut brand generates about 80% of its sales, with reported turnover of Rs 129 crore in FY23, Rs 107 crore in FY24, and Rs 110 crore in FY25, and Emami projects about Rs 180 crore in FY26.
- Emami, which first took roughly a 26% stake in 2023, has named Harkirat Bedi as Axiom’s chief executive to steer the brand under its ownership.